Purdue Pharma and the Sackler families agreed Thursday to increase their financial contribution to $7.4 billion to resolve mass opioid litigation.

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role in the opioid epidemic. The deal follows the U.S. Supreme Court’s rejection ...

Bankrupt Purdue Pharma LP and its owners have agreed to pay $7.4 billion to a group of US states and other parties to settle long-running litigation over OxyContin’s role in the deadly opioid ...

NEW YORK — Purdue Pharma and its Sackler family owners have reached a new $7.4 billion settlement to resolve thousands of lawsuits alleging that the pain medication OxyContin caused a widespread ...

The first full year of the post-COVID-pandemic era was characterized in the United States by continued economic recovery, persistently high consumer interest rates—despite three cuts in the ...

SALT LAKE CITY — Utah is expected to join a settlement with Purdue Pharma, makers of OxyContin, that will resolve thousands of lawsuits alleging that the pain medication caused a widespread ...

McKinsey & Company Inc., a management consulting firm, recently agreed to pay $650 million to resolve a civil and criminal investigation into consulting work performed by the firm with opioids ...

Gifting allows recipients to access the article for free. Bankrupt Purdue Pharma LP and members of the billionaire Sackler family agreed to pay $7.4 billion to a group of US states, including ...